Creating affordable contrast agents for advanced imaging techniques
Rapid low-cost production of contrast agents for metabolic imaging
['FUNDING_R21'] · WAYNE STATE UNIVERSITY · NIH-10893309
This study is working on a new way to make special dyes for PET scans that can help doctors see important details about your health, like detecting cancer, more quickly and safely, so you can get better results in less time.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | WAYNE STATE UNIVERSITY (nih funded) |
| Locations | 1 site (DETROIT, UNITED STATES) |
| Trial ID | NIH-10893309 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a new method for producing contrast agents used in metabolic imaging, specifically for Positron Emission Tomography (PET) scans. By utilizing hyperpolarization techniques, the study aims to enhance the detection of low-concentration metabolites in real-time, significantly reducing the time and radiation exposure associated with traditional imaging methods. Patients will benefit from faster scans and improved diagnostic accuracy for conditions like cancer. The research is being conducted at Wayne State University in Detroit.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients undergoing PET scans for cancer diagnosis or treatment monitoring.
Not a fit: Patients who are not undergoing imaging procedures or those with conditions that do not require metabolic imaging may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to quicker and safer imaging procedures for patients, improving the diagnosis and monitoring of serious diseases.
How similar studies have performed: Previous research has shown promise in using hyperpolarized agents for imaging, indicating a potential for success in this novel approach.
Where this research is happening
DETROIT, UNITED STATES
- WAYNE STATE UNIVERSITY — DETROIT, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CHEKMENEV, EDUARD — WAYNE STATE UNIVERSITY
- Study coordinator: CHEKMENEV, EDUARD
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.